Health

Chairman:  Joe Pitts (PA-16)
Jurisdiction: 
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Members

Republicans

Chairman: Joe Pitts (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Ed Whitfield (KY)
John Shimkus (IL)
Mike Rogers (MI)
Tim Murphy (PA)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Bill Cassidy (LA)
Brett Guthrie (KY)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Frank Pallone, Jr. (NJ)
John D. Dingell (MI)
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
Jim Matheson (UT)
Gene Green (TX)
G.K. Butterfield (NC)
John Barrow (GA)
Donna M. Christensen (VI)
Kathy Castor (FL)
John Sarbanes (MD)
Henry A. Waxman (CA)

May 9, 2013 | Letter

Excerpt: We continue to have questions about how CPPW funds have been spent by HHS. The Committee supports initiatives designed to improve health outcomes and reduce chronic diseases.

>>
May 9, 2013 | Press Release

WASHINGTON, DC – Leaders of the House Energy and Commerce Committee yesterday sent a letter to public health officials in all 50 states and the District of Columbia to examine how each state regulates and monitors abortion clinics and protects the hea

>>
May 8, 2013 | Letter

To read a copy of the letter sent to the following state agencies, click here.

>>
May 8, 2013 | Press Release

WASHINGTON, DC – The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today advanced legislation reauthorizing two important drug user fee programs for new and generic animal drugs and a bill to secure America’s prescription drug supply chain.

>>

Pages